Atlas Trials

A Study to Evaluate the Efficacy and Safety of Apremilast in Patients of Chronic and Recurrent Erythema Nodosum Leprosum

Clinical trial NCT04822909 · COMPLETED

Trial details

NCT number
NCT04822909
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Erythema Nodosum Leprosum
Start date
2019-09-15
Primary completion
2020-03-14
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.